Rossari Biotech Limited — Quarter and year ended 31 March 2026
| DCS-CRD | Listing Compliance |
|---|---|
| BSE Limited | National Stock Exchange of India Limited |
| First Floor, New Trade Wing | Exchange Plaza, 5th Floor |
| Rotunda Building, Phiroze Jeejeebhoy Towers | Plot No. C/1, ‘G’ Block, Bandra-Kurla Complex |
| Dalal Street, Fort Mumbai 400001 | Bandra East Mumbai 400051 |
| Fax No. 2272 3121/2037/2039 | Fax No. 2659 8237/8238 |
| Stock Code: 543213 | Stock Code: ROSSARI |
| Sr. No. | Particulars | Disclosure |
|---|---|---|
| 6. | Information as required pursuant to BSE Circular with ref. no. LIST/COMP/14/2018-19 and the National Stock Exchange of India Limited Circular with ref. no. NSE/CML/2018/24, both dated 20 June 2018 | Mr. Gill satisfies all the criteria as set out in Section 149 and other applicable provisions of the Companies Act, 2013 (“the Act”) and Regulation 16 of the Listing Regulations, for being eligible to be appointed as Non-Executive Independent Director. He is not disqualified from being appointed as a Director in terms of Section 164 of the Act.
We confirm that Mr. Gill has not been debarred from holding office of Director by virtue of any Order passed by the Securities and Exchange Board of India or any other authority. |
| Sr. No. | Particular | Disclosure – Rossari Employee Stock Option Plan – 2019 |
|---|---|---|
| 1. | Company name and address of Registered Office | Rossari Biotech Limited CIN: L24100MH2009PLC194818 Registered Office: Rossari House, Golden Oak, LBS Marg, Surya Nagar, Opp. Mahindra Showroom, Vikhroli (West), Mumbai – 400079. |
| 2. | Name of the Stock Exchanges on which the Company’s shares are listed | 1. BSE Limited (BSE) 2. National Stock Exchange of India Limited (NSE) |
| 3. | Filing date of the statement referred in regulation 10(b) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 with Stock Exchange | Filing date of statement is as follows: 1. BSE Limited: May 20, 2021 2. National Stock Exchange of India Limited: May 25, 2021 |
| 4. | Filing No., if any | BSE: 129899 NSE: 26888 |
| 5. | Title of the Scheme pursuant to which shares are issued, if any | Rossari Employee Stock Option Plan – 2019 |
| 6. | Kind of security to be listed | Equity Shares |
| 7. | Par Value of the shares | Rs. 2/- |
| 8. | Date of Issue of shares | April 27, 2026 |
| 9. | Number of shares issued | 8250 Shares |
| 10. | Share Certificate No., if applicable | Not applicable |
| 11. | Distinctive Number of the shares, if applicable | 55383367 to 55391616 |
| 12. | ISIN of the shares if issued in Demat | INE02A801020 |
| 13. | Exercise price per share | Rs. 425/- |
| 14. | Premium per share | Rs. 423/- |
| 15. | Total Issued shares after this issue | 55391616 Shares |
| 16. | Total Issued share capital after this issue | Rs. 11,07,83,232 |
| 17. | Details of any lock-in on the shares | Not applicable |
| 18. | Date of expiry of lock-in | Not applicable |
| 19. | Whether shares identical in all respects to existing shares, if not, when will they become identical | All equity shares allotted pursuant to exercise of stock options shall rank pari-passu with the existing equity shares of the Company |
| 20. | Details of listing fees, if applicable | Not applicable |
| Particulars | Quarter ended 31st March, 2026 Refer Note 5 | Quarter ended 31st December, 2025 Unaudited | Quarter ended 31st March, 2025 Refer Note 5 | Year Ended 31st March, 2026 Audited | Year Ended 31st March, 2025 Audited |
|---|---|---|---|---|---|
| I INCOME | |||||
| Revenue from operations | 6,848.62 | 5,816.80 | 5,795.62 | 23,963.65 | 20,802.94 |
| Other Income | 190.65 | 5.09 | 17.91 | 223.78 | 40.09 |
| Total Income | 7,039.27 | 5,821.89 | 5,813.53 | 24,187.43 | 20,843.03 |
| II EXPENSES | |||||
| Cost of materials consumed | 4,444.68 | 4,175.99 | 3,697.71 | 16,036.78 | 12,996.44 |
| Purchase of stock-in-trade | 240.97 | 109.73 | 338.84 | 934.15 | 1,647.68 |
| Changes in inventories of finished goods, work-in-progress and stock-in-trade | 271.58 | (277.71) | (20.07) | (283.66) | (311.15) |
| Employee benefits expense | 392.28 | 402.56 | 354.89 | 1,547.48 | 1,323.30 |
| Finance costs | 90.59 | 76.65 | 55.02 | 285.43 | 178.11 |
| Depreciation and amortisation expenses | 235.28 | 196.14 | 182.19 | 791.24 | 670.73 |
| Other expenses | 726.60 | 717.50 | 729.34 | 2,869.87 | 2,495.85 |
| Total Expenses | 6,401.98 | 5,400.86 | 5,337.92 | 22,181.29 | 19,000.96 |
| III Profit before Share of profit of joint venture, associate, exceptional items and tax [I-II] | 637.29 | 421.03 | 475.61 | 2,006.14 | 1,842.07 |
| IV Share of profit of joint venture and associate | 5.14 | 3.98 | 1.45 | 19.01 | 9.78 |
| V Profit before exceptional items and tax [III+IV] | 642.43 | 425.01 | 477.06 | 2,025.15 | 1,851.85 |
| VI Exceptional items | – | – | – | – | – |
| VII Profit before tax [V-VI] | 642.43 | 425.01 | 477.06 | 2,025.15 | 1,851.85 |
| VIII Tax Expense | |||||
| Current tax charge | 159.15 | 132.08 | 144.19 | 612.79 | 590.71 |
| Deferred tax charge / (credit) | 23.61 | (34.81) | (11.57) | (79.77) | (102.64) |
| Total Tax Expense | 182.76 | 97.27 | 132.62 | 533.02 | 488.07 |
| IX Profit after tax [VII-VIII] | 459.67 | 327.74 | 344.44 | 1,492.13 | 1,363.78 |
| X Other comprehensive income / (loss) | |||||
| A Items that will not be reclassified to profit or loss | |||||
| i Remeasurements of the defined benefit plans | 11.24 | (2.87) | (13.98) | 1.86 | (12.67) |
| ii Income tax relating to items that will not be reclassified to profit or loss | (2.83) | 0.72 | 3.51 | (0.47) | 3.18 |
| B Items that will be reclassified subsequently to profit or loss | |||||
| i Exchange difference on translation of foreign operations | (2.95) | 0.94 | (0.76) | (0.84) | (0.76) |
| ii Income tax relating to items that will be reclassified to profit or loss | 0.74 | (0.53) | – | 0.21 | – |
| Total other comprehensive income/(loss) | 6.20 | (1.74) | (11.23) | 0.76 | (10.25) |
| XI Total comprehensive income (IX + X) | 465.87 | 326.00 | 333.21 | 1,492.89 | 1,353.53 |
| Profit for the period/year attributable to | |||||
| Owners of the Company | 459.67 | 327.74 | 344.44 | 1,492.13 | 1,363.78 |
| Non Controlling Interest | – | – | – | – | – |
| 459.67 | 327.74 | 344.44 | 1,492.13 | 1,363.78 | |
| Other Comprehensive Income/(Loss) attributable to | |||||
| Owners of the Company | 6.20 | (1.74) | (11.23) | 0.76 | (10.25) |
| Non Controlling Interest | – | – | – | – | – |
| 6.20 | (1.74) | (11.23) | 0.76 | (10.25) | |
| Total Comprehensive Income attributable to | |||||
| Owners of the Company | 465.87 | 326.00 | 333.21 | 1,492.89 | 1,353.53 |
| Non Controlling Interest | – | – | – | – | – |
| 465.87 | 326.00 | 333.21 | 1,492.89 | 1,353.53 | |
| Paid up equity share capital (Face value of Rs 2.00 per share) | 110.77 | 110.76 | 110.73 | 110.77 | 110.73 |
| Other equity | – | – | – | 13,222.72 | 11,743.76 |
| XII Earnings per equity share (in Rs.) | |||||
| Basic | 8.30* | 5.92* | 6.22* | 26.95 | 24.66 |
| Diluted | 8.29* | 5.91 | 6.21 | 26.93 | 24.63 |
| Particulars | Rs. In million | As at 31st March, 2026 Audited | As at 31st March, 2025 Audited |
|---|---|---|---|
| ASSETS | |||
| NON-CURRENT ASSETS | |||
| (a) Property, Plant and Equipment | 4,665.03 | 2,851.61 | |
| (b) Right of Use Assets | 940.35 | 683.73 | |
| (c) Capital Work-in-Progress | 1,733.01 | 1,401.87 | |
| (d) Goodwill | 1,187.11 | 1,187.11 | |
| (e) Other Intangible Assets | 1,052.02 | 1,261.00 | |
| (f) Investments accounted for using the equity method | 269.82 | 262.76 | |
| (g) Financial Assets | |||
| (i) Investments | 2.12 | 2.11 | |
| (ii) Other Financial Assets | 88.48 | 74.35 | |
| (h) Income Tax Assets (Net) | 119.79 | 77.47 | |
| (i) Deferred Tax Assets (Net) | 149.43 | 105.13 | |
| (j) Other Non-current Assets | 243.99 | 623.33 | |
| TOTAL NON-CURRENT ASSETS | 10,451.15 | 8,530.47 | |
| CURRENT ASSETS | |||
| (a) Inventories | 4,045.45 | 3,550.80 | |
| (b) Financial Assets | |||
| (i) Investments | 351.00 | 573.13 | |
| (ii) Trade Receivables | 5,574.13 | 4,745.04 | |
| (iii) Cash and Cash Equivalents | 753.07 | 442.02 | |
| (iv) Bank Balances other than (iii) above | 169.07 | 129.61 | |
| (v) Loans | 11.53 | 12.43 | |
| (vi) Other Financial Assets | 59.16 | 32.31 | |
| (c) Other Current Assets | 1,395.59 | 933.93 | |
| TOTAL CURRENT ASSETS | 12,359.00 | 10,419.27 | |
| Non-Current Assets classified as held for sale | 77.77 | 12.10 | |
| TOTAL ASSETS | 22,887.92 | 18,961.84 |
| Particulars | Rs. In million | As at 31st March, 2026 Audited | As at 31st March, 2025 Audited |
|---|---|---|---|
| EQUITY AND LIABILITIES | |||
| EQUITY | |||
| (a) Equity Share Capital | 110.77 | 110.73 | |
| (b) Other Equity | 13,222.72 | 11,743.76 | |
| Equity Attributable to Owners of the Company | 13,333.49 | 11,854.49 | |
| TOTAL EQUITY | 13,333.49 | 11,854.49 |
| Particulars | Rs. In million | As at 31st March, 2026 Audited | As at 31st March, 2025 Audited |
|---|---|---|---|
| LIABILITIES | |||
| NON-CURRENT LIABILITIES | |||
| (a) Financial Liabilities | |||
| (i) Borrowings | 943.26 | 1,000.32 | |
| (ii) Lease Liabilities | 202.53 | 223.07 | |
| (b) Provisions | 82.60 | 52.57 | |
| (c) Deferred Tax Liabilities (Net) | 430.46 | 465.67 | |
| TOTAL NON CURRENT LIABILITIES | 1,658.85 | 1,741.63 |
| Particulars | Rs. In million | As at 31st March, 2026 Audited | As at 31st March, 2025 Audited |
|---|---|---|---|
| CURRENT LIABILITIES | |||
| (a) Financial Liabilities | |||
| (i) Borrowings | 3,136.60 | 879.41 | |
| (ii) Lease Liabilities | 76.98 | 77.18 | |
| (iii) Trade Payables | |||
| a) total outstanding dues of Micro Enterprises and Small Enterprises | 358.53 | 235.24 | |
| b) total outstanding dues of Creditors other than Micro Enterprises and Small Enterprises | 2,875.99 | 2,628.11 | |
| ( |